Healio: Driver training software program associated with fewer distractions in ADHD youth
Healio highlighted a recent trial published by University of Cincinnati and Cincinnati Children's Hospital Medical Center researchers that found a driver training software program reduced how often adolescent drivers with ADHD took long glances away from the roadway.
Led by Jeffery N. Epstein, PhD, professor in UC's Department of Pediatrics in the College of Medicine, director of the Cincinnati Children's Center for ADHD and a pediatric psychologist, the research was published in the New England Journal of Medicine.
Teenage drivers with ADHD are twice as likely than neurotypical teens to be in an accident, the researchers wrote, noting a struggle for these teens to sustain visual attention while driving.
In the trial, the researchers evaluated the effectiveness of an enhanced version of the Focused Concentration and Attention Learning (FOCAL+) program, a desktop-based software program that features multiple sessions and simulator training "with immediate auditory feedback" designed to reduce long glances away from the road of 2 seconds or longer.
The teen drivers with ADHD randomly assigned to the FOCAL+ program were found to have significantly fewer long glances from the roadway.
Featured photo at top courtesy of Unsplash.
Related Stories
Revolutionary AI technology enhances diagnosis of substance use disorder
February 6, 2026
MSN, Bioengineer and other outlets highlight a new study by researchers at the University of Cincinnati who developed a novel AI to predict substance use disorder.
Powerful AI can help diagnose substance use disorder
February 5, 2026
A new study by the University of Cincinnati uses a novel artificial intelligence to predict substance use disorder-defining behaviors with up to 83% accuracy.
'Time is brain' again, now for control of intracerebral hemorrhage
February 5, 2026
MedPage Today highlighted research led by the University of Cincinnati's Joseph Broderick that found administering a synthetic protein can reduce bleeding and improve outcomes for certain patients at the highest risk of continued bleeding following a type of stroke called an intracerebral hemorrhage (ICH).